Myocarditis, or inflammation of the heart muscle, is most commonly triggered by viral infections. But it can also result from autoimmune diseases, certain medications, and other infections caused by bacteria or parasites. In most cases, the inflammation happens not because a virus directly destroys heart cells, but because the body’s immune response to an infection inadvertently damages the heart in the process.
Viral Infections Are the Most Common Cause
The viruses most frequently linked to myocarditis include coxsackieviruses (a type of enterovirus), adenoviruses, and parvovirus B19. These are common viruses that cause everyday illnesses like colds, stomach bugs, and mild rashes in most people. Only a small fraction of those infected develop heart inflammation.
Coronaviruses, including SARS-CoV-2, can also trigger myocarditis. They may damage the heart directly, provoke an overwhelming inflammatory response (sometimes called a cytokine storm), or set off an autoimmune reaction against heart tissue. HIV, influenza, and hepatitis C have been linked to myocarditis as well.
The typical pattern looks like this: you come down with what feels like a flu or upper respiratory infection, and within one to two weeks, cardiac symptoms appear. These can include chest pain, shortness of breath, fatigue, or a rapid or irregular heartbeat. Some people never realize they had an infection at all before the heart symptoms start.
How Infections Lead to Heart Damage
The progression from a routine infection to heart inflammation generally unfolds in three phases. In the first few days, a virus enters the body and may reach the heart, where it infects heart muscle cells, the cells lining blood vessels, or the connective tissue around them. Different viruses target different cell types: coxsackieviruses primarily infect heart muscle cells, while parvovirus B19 tends to target the cells lining small blood vessels in the heart.
Over the next one to four weeks, the immune system ramps up its response. White blood cells flood into the heart to fight the virus, but in doing so, they can damage healthy heart tissue. This is the subacute phase, and it’s often when symptoms become noticeable. In most people, the immune system clears the virus and the inflammation resolves. But in some cases, the immune response doesn’t shut off properly. Chronic inflammation can persist for months or even years, gradually weakening the heart muscle and potentially leading to a condition called dilated cardiomyopathy, where the heart enlarges and pumps less effectively.
One key mechanism behind this persistent damage is molecular mimicry. Parts of the virus can look structurally similar to proteins in the heart. The immune system, trained to attack the virus, gets confused and attacks heart tissue that resembles it. Interestingly, researchers have found that even certain gut bacteria produce proteins that mimic heart muscle proteins, which in rare cases can trigger severe myocarditis without a viral infection at all.
Autoimmune Diseases and the Heart
Several autoimmune conditions can cause myocarditis independently of any infection. Lupus is probably the best-known example, but others include granulomatosis with polyangiitis (formerly called Wegener’s granulomatosis), giant cell arteritis, and Takayasu’s arteritis. In these diseases, the immune system is already chronically overactive, and the heart muscle can become collateral damage.
Giant cell myocarditis deserves special mention because it’s rare but particularly aggressive. It involves large immune cells forming clusters in the heart tissue, and it can progress rapidly to heart failure if not treated.
Medications and Toxins
Certain medications can inflame the heart muscle through either a direct toxic effect or an allergic-type hypersensitivity reaction. One of the most studied examples is clozapine, an antipsychotic medication. A meta-analysis found that roughly 0.7% of patients starting clozapine develop myocarditis, though screening programs in parts of Australia have detected rates as high as 8.5%. The mortality rate once clozapine-associated myocarditis develops ranges from 21 to 50%, which is why patients starting this drug undergo weekly blood tests and heart monitoring for the first month.
Certain cancer immunotherapy drugs, particularly immune checkpoint inhibitors, can also trigger myocarditis by unleashing the immune system in ways that affect the heart. Other medications linked to heart inflammation include some antibiotics, antiseizure drugs, and diuretics, typically through hypersensitivity reactions rather than direct toxicity.
Parasites and Bacterial Infections
Outside of viruses, the parasite that causes Chagas disease is one of the most significant causes of myocarditis worldwide. Chagas disease, caused by Trypanosoma cruzi and spread by triatomine insects (sometimes called “kissing bugs”), remains a major public health problem in Latin America. The parasite can persist in the heart at low levels for decades, triggering ongoing immune-mediated damage, disrupting the heart’s blood supply at the microvascular level, and damaging the nerves that control heart rhythm. This slow, relentless process leads to the distinctive chronic heart disease seen in Chagas patients, characterized by widespread inflammation, cell death, and scarring.
Bacterial infections are less common causes but still relevant. Lyme disease, caused by tick-borne bacteria, can affect the heart’s electrical system. Diphtheria produces a toxin that can directly damage heart cells.
Vaccines and Myocarditis Risk
Myocarditis after vaccination is rare but became widely discussed during the COVID-19 pandemic. Cases following mRNA vaccines occurred most frequently in adolescent and young adult males, typically within seven days of the second dose. Cases were also seen in females, other age groups, and after other doses, but at lower rates. The suspected mechanisms are similar to infection-related myocarditis: molecular mimicry and an exaggerated inflammatory response. Most vaccine-associated cases have been mild and self-limiting, with patients recovering fully.
Who Is Most at Risk
Myocarditis can strike anyone, but certain groups face higher odds. Males are affected significantly more often than females, and this gap widens with age. A nationwide Finnish study found that boys had roughly three times the incidence of girls overall, with rates of 2.92 per 100,000 person-years for boys compared to 0.94 for girls. Among children aged 11 to 15, boys were nearly four times more likely to develop myocarditis. The highest rate recorded was in 15-year-old boys, at 18.1 per 100,000 person-years.
Overall incidence remained relatively stable through the first 11 years of life, then climbed sharply in adolescence. The reasons for this male predominance aren’t fully understood but likely involve differences in immune response and hormonal factors.
How Myocarditis Is Detected
If myocarditis is suspected, doctors typically start with blood tests looking for elevated levels of troponin, a protein released when heart cells are damaged. Higher troponin levels correlate with more extensive scarring in the heart, as confirmed by cardiac MRI studies showing a direct relationship between troponin concentration and the volume of damaged tissue.
Cardiac MRI is considered the best noninvasive tool for confirming myocarditis. It can reveal three key findings known as the Lake Louise Criteria: scarring (seen as bright areas on specific imaging sequences), increased blood flow suggesting active inflammation, and swelling of the heart muscle tissue. Of these, scarring appears to be the most specific marker of actual heart cell death, while swelling may reflect broader inflammatory processes that don’t necessarily involve permanent damage. This distinction matters because it helps predict whether the heart is likely to recover fully or sustain lasting injury.